Biotech on the Web

New Study Reveals Two Genes Associated with High Risk for ALS

Apr 16, 2018Biotech (General), Clinical Trials

Share:Genetic mutations in two previously unrecognized genes, the microtubule-associated protein tau (MAPT) and BNIP1 genes, are associated with elevated risk for amyotrophic lateral sclerosis (ALS). The study with that finding “Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum,” was published in the journal JAMA Neurology. As seen in other neurodegenerative diseases, abnormal accumulation of […]

Newly-discovered human organ may help explain how cancer spreads

Mar 29, 2018Biotech (General)

Share:… Cancer transport But as well as protecting organs, the network may also aid the spread of cancer. When Theise’s team looked at samples taken from people with invasive cancers, they found evidence that cancer cells that had worked their way out of their original tissues could find their way into these channels, which took […]

Servier and Treventis begin strategic research partnership in neurodegenerative diseases

Mar 21, 2018Biotech (General)

Share:March 8, 2018 – Servier, Pfizer Inc. (NYSE: PFE) and Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), today announced that results from the two phase 1 trials with UCART19, the allogeneic anti-CD19 CAR T-cell product being developed by Servier and Pfizer, will be presented during the European society for Blood and Marrow Transplantation (EBMT) Annual Meeting […]

Democrats sink House vote on Trump-backed drug bill

Mar 14, 2018Biotech (General), Clinical Trials, Policy

Share:House Republicans failed Tuesday evening to pass a “right-to-try” bill that would give terminally ill patients access to experimental drugs without FDA authorization after failing to muster enough votes to approve it through an expedited process. The 259-140 vote fell short of the necessary two-thirds support from the House chamber. The failed vote is a […]

BCLI: PHASE 3 TRIAL IN ALS ENROLLING PATIENTS

Mar 14, 2018Biotech (General), Biotech Stocks To Watch

Share:BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) has enrolled the first patients in the Phase 3 clinical trial of NurOwn® (NCT03280056) for the treatment of amyotrophic lateral sclerosis (ALS). The trial is taking place at six leading U.S. Medical centers. It is a randomized, double blind, placebo controlled, multi-dose trial that is expected to enroll approximately 200 […]

Japan’s New Drug: One Pill May Stop The Flu in Just One Day

Feb 27, 2018Biotech (General), Biotech Stocks To Watch

Share:One day, you may be able to stop flu viruses in your body in just one day with just one pill. Based on an announcement yesterday, that day may be someday very soon in May in Japan. On Friday, Japanese pharmaceutical company Shionogi announced that the flu medication that they have developed, Xofluza, otherwise known […]

Digital Drug Development Services Provider Transparency Life Sciences Raises $5.0 Million in Series A Financing

Feb 15, 2018Biotech (General), Biotech and the Internet

Share:New York, NY — February 15, 2018 — Transparency Life Sciences (TLS), a pioneer in digital drug development clinical services, today announced completion of a $5.0 million Series A financing led by venture investor New Ventures III. Existing private investors also participated. TLS will use the new financing to expand the company’s technology platform and […]

New Israeli bandage stops uncontrollable bleeding

Feb 14, 2018Biotech (General)

Share:Was Once Thought to Be ‘Uncontrollable’ Bleeding The new technology is hailed by its inventors as a life-saving bandage that can succeed where conventional treatment procedures might fail to stop a deadly hemorrhage. More at: https://www.haaretz.com/israel-news/new-israeli-bandage-can-stop-uncontrollable-bleeding-1.5402251

Global Angiopoietin 1 Receptor Market 2018 – Pfizer, Eddingpharm, Teva Pharmaceutical Industries Ltd

Feb 7, 2018Biotech (General)

Share:The Angiopoietin 1 Receptor Market 2018 Research Report studies an absolute and exhaustive study on Angiopoietin 1 Receptor industry volume, Market Share, Industry Trends, Angiopoietin 1 Receptor Growth appearances, the wide range of applications, Utilization ratio, Supply including demand analysis, production capacity, Price during the Forecast period from 2018 to 2023. High Use of Angiopoietin 1 Receptor […]

New York sketches out $500M plan to build a biotech hub

Feb 3, 2018Biotech (General), Biotech and the Internet

Share:New York City is doubling down on its long-discussed, never-realized dream of building a biotech hub to rival South San Francisco and Boston. The latest iteration of the dream comes backed by a $500 million financing package and a goal to quadruple the amount of R&D space in the city. City officials sketched out the […]